Evaluation of recombinant human IGF-1/IGFBP-3 on intraventricular hemorrhage prevention and survival in the preterm rabbit pup model

Sci Rep. 2023 Nov 13;13(1):19847. doi: 10.1038/s41598-023-46611-0.

Abstract

Insulin-like growth factor-1 (IGF-1) is essential for normal brain development and regulates processes of vascular maturation. The pathogenesis of intraventricular hemorrhage (IVH) relates to the fragility of the immature capillaries in the germinal matrix, and its inability to resist fluctuations in cerebral blood flow. In this work, using different experimental setups, we aimed to (i) establish an optimal time-point for glycerol-induction of IVH in relation to time-point of recombinant human (rh) IGF-1/rhIGFBP-3 administration, and (ii) to evaluate the effects of a physiologic replacement dose of rhIGF-1/rhIGFBP-3 on prevention of IVH and survival in the preterm rabbit pup. The presence of IVH was evaluated using high-frequency ultrasound and post-mortem examinations. In the first part of the study, the highest incidence of IVH (> 60%), occurred when glycerol was administered at the earliest timepoint, e.g., 6 h after birth. At later time-points (18 and 24 h) the incidence decreased substantially. In the second part of the study, the incidence of IVH and mortality rate following rhIGF-1/rhIGFBP-3 administration was not statistically different compared to vehicle treated animals. To evaluate the importance of maintaining intrauterine serum levels of IGF-1 following preterm birth, as reported in human interventional studies, additional studies are needed to further characterize and establish the potential of rhIGF-1/rhIGFBP-3 in reducing the prevalence of IVH and improving survival in the preterm rabbit pup.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cerebral Hemorrhage / drug therapy
  • Cerebral Hemorrhage / prevention & control
  • Female
  • Glycerol
  • Humans
  • Infant, Newborn
  • Insulin-Like Growth Factor Binding Protein 3
  • Insulin-Like Growth Factor I / metabolism
  • Peptide Hormones*
  • Premature Birth* / drug therapy
  • Rabbits
  • Recombinant Proteins / therapeutic use

Substances

  • Insulin-Like Growth Factor I
  • Insulin-Like Growth Factor Binding Protein 3
  • Glycerol
  • Recombinant Proteins
  • Peptide Hormones